FDA Receives New Drug Application for SH-105 in Breast and Ovarian Cancer January 15th 2024January 15th 2024 Read More
OncLive/ SH-105 Gets Accepted for FDA Review in Breast and Ovarian Cancer January 15th 2024January 15th 2024 Read More